Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/jama.297.3.262-b | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fixed-Dose Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Pulmonary Embolism Associated with COVID-19.
Viruses
July 2022
Department of Angiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Fixed-dose ultrasound-assisted catheter-directed thrombolysis (USAT) rapidly improves hemodynamic parameters and reverses right ventricular dysfunction caused by acute pulmonary embolism (PE). The effectiveness of USAT for acute PE associated with coronavirus disease 2019 (COVID-19) is unknown. The study population of this cohort study consisted of 36 patients with an intermediate-high- or high-risk acute PE treated with a fixed low-dose USAT protocol (r-tPA 10-20 mg/15 h).
View Article and Find Full Text PDFAnticoagulation for the initial treatment of venous thromboembolism in people with cancer.
Cochrane Database Syst Rev
December 2021
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Background: Compared with people without cancer, people with cancer who receive anticoagulant treatment for venous thromboembolism (VTE) are more likely to develop recurrent VTE.
Objectives: To compare the efficacy and safety of three types of parenteral anticoagulants (i.e.
Prevention of Venous Thromboembolism in Microvascular Surgery Patients Using Weight-Based Unfractionated Heparin Infusions.
J Reconstr Microsurg
June 2022
Plastic Surgery Northwest, Spokane, Washington.
Background: Unfractionated heparin infusions are commonly used in microvascular surgery to prevent microvascular thrombosis. Previously, fixed-dose heparin infusions were believed to provide sufficient venous thromboembolism (VTE) prophylaxis; however, we now know that this practice is inadequate for the majority of patients. Anti-factor Xa (aFXa) level is a measure of unfractionated heparin efficacy and safety.
View Article and Find Full Text PDFWeight-adjusted versus fixed dose heparin thromboprophylaxis in hospitalized obese patients: A systematic review and meta-analysis.
Eur J Intern Med
June 2021
Department of Internal Medicine, University of Padua, Padua, Italy.
Background: Fixed dose unfractionated or low molecular weight heparin is the recommended treatment for venous thromboembolism (VTE) prevention in hospitalized patients. However, its efficacy has been questioned in obese population. Results of previous studies on weight-adjusted doses of heparin for VTE prevention are contradictory.
View Article and Find Full Text PDFPragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
Am J Trop Med Hyg
January 2021
8Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.
New studies of COVID-19 are constantly updating best practices in clinical care. Often, it is impractical to apply recommendations based on high-income country investigations to resource limited settings in low- and middle-income countries (LMICs). We present a set of pragmatic recommendations for the management of anticoagulation and thrombotic disease for hospitalized patients with COVID-19 in LMICs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!